HomeCompareBSX vs LUMN

BSX vs LUMN: Dividend Comparison 2026

BSX yields 3.18% · LUMN yields 28.78%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LUMN wins by $4.8K in total portfolio value
10 years
BSX
BSX
● Live price
3.18%
Share price
$62.93
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.2K
Annual income
$0.32
Full BSX calculator →
LUMN
LUMN
● Live price
28.78%
Share price
$6.95
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.0K
Annual income
$3.58
Full LUMN calculator →

Portfolio growth — BSX vs LUMN

📍 LUMN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBSXLUMN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BSX + LUMN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BSX pays
LUMN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BSX
Annual income on $10K today (after 15% tax)
$270.14/yr
After 10yr DRIP, annual income (after tax)
$0.27/yr
LUMN
Annual income on $10K today (after 15% tax)
$2,446.04/yr
After 10yr DRIP, annual income (after tax)
$3.04/yr
At 15% tax rate, LUMN beats the other by $2.77/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BSX + LUMN for your $10,000?

BSX: 50%LUMN: 50%
100% LUMN50/50100% BSX
Portfolio after 10yr
$22.6K
Annual income
$1.95/yr
Blended yield
0.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BSX right now

BSX
No analyst data
Altman Z
3.9
Piotroski
7/9
LUMN
Analyst Ratings
4
Buy
17
Hold
7
Sell
Consensus: Hold
Price Target
$7.08
+1.9% upside vs current
Range: $6.00 — $8.00
Altman Z
-0.3
Piotroski
3/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BSX buys
0
LUMN buys
0
No recent congressional trades found for BSX or LUMN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBSXLUMN
Forward yield3.18%28.78%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%-50%
Portfolio after 10y$20.2K$25.0K
Annual income after 10y$0.32$3.58
Total dividends collected$321.00$3.1K
Payment frequencyquarterlyquarterly
SectorHealthcareTelecom

Year-by-year: BSX vs LUMN ($10,000, DRIP)

YearBSX PortfolioBSX Income/yrLUMN PortfolioLUMN Income/yrGap
1← crossover$10,859$158.91$12,139$1,438.85$1.3KLUMN
2$11,700$80.63$13,805$816.17$2.1KLUMN
3$12,559$40.60$15,205$433.73$2.6KLUMN
4$13,459$20.36$16,492$223.23$3.0KLUMN
5$14,411$10.20$17,760$113.15$3.3KLUMN
6$15,425$5.10$19,060$56.94$3.6KLUMN
7$16,507$2.55$20,423$28.55$3.9KLUMN
8$17,664$1.28$21,867$14.30$4.2KLUMN
9$18,901$0.64$23,405$7.15$4.5KLUMN
10$20,225$0.32$25,046$3.58$4.8KLUMN

BSX vs LUMN: Complete Analysis 2026

BSXHealthcare

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Full BSX Calculator →

LUMNTelecom

Lumen Technologies, Inc., a facilities-based technology and communications company, provides various integrated products and services under the Lumen, Quantum Fiber, and CenturyLink brands to business and residential customers in the United States and internationally. The company operates in two segments, Business and Mass Markets. It offers compute and application services, such as cloud services, IT solutions, unified communication and collaboration solutions, colocation and data center services, content delivery services, and managed security services; and IP and data services, including VPN data network, Ethernet, internet protocol (IP), and voice over internet protocol. The company also provides fiber infrastructure services comprising high bandwidth optical wavelength networks; and unlit optical fiber and related professional services. In addition, it offers voice and other services, including private line services, a direct circuit or channel specifically dedicated for connecting two or more organizational sites; a portfolio of traditional time division multiplexing voice services; and synchronous optical network-based Ethernet, legacy data hosting services, and conferencing services. As of December 31, 2021, the company served approximately 4.5 million broadband subscribers. The company was formerly known as CenturyLink, Inc. and changed its name to Lumen Technologies, Inc. in September 2020. Lumen Technologies, Inc. was incorporated in 1968 and is headquartered in Monroe, Louisiana.

Full LUMN Calculator →
📬

Get this BSX vs LUMN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BSX vs SCHDBSX vs JEPIBSX vs OBSX vs KOBSX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.